Genomic

Dataset Information

0

Glioma International Case Control Study (GICC)


ABSTRACT:

The main goals of the GICC Study were: 1) to identify novel genetic risk variants for glioma, as well as validate variants implicated by previous genome-wide association studies of glioma; and 2) to explore biologically relevant gene-gene and gene-environment interactions in glioma susceptibility. The GICC Study includes participants from the following centers: Brigham and Women's Hospital (Boston, Massachusetts), Case Western Reserve University (Cleveland, Ohio), Columbia University (New York, New York), the Danish Cancer Society Research Centre (Copenhagen, Denmark), Duke University (Durham, North Carolina), the University of Texas MD Anderson Cancer Center (Houston, Texas), Memorial Sloan Kettering Cancer Center (New York, New York), the Mayo Clinic (Rochester, Minnesota), NorthShore HealthSystem (Chicago, Illinois), Umea University (Umea, Sweden), the University of California, San Francisco (San Francisco, California), the University of Southern California (Los Angeles, California), and the Institute of Cancer Research (London, United Kingdom).

PROVIDER: phs001319 | dbGaP |

SECONDARY ACCESSION(S): PRJNA377600PRJNA377601

REPOSITORIES: dbGaP

Similar Datasets

2014-07-30 | MSV000078796 | MassIVE
| 2188452 | ecrin-mdr-crc
2012-12-06 | E-GEOD-42739 | biostudies-arrayexpress
2012-12-06 | E-GEOD-42738 | biostudies-arrayexpress
2024-09-24 | GSE268921 | GEO
2021-03-04 | GSE164457 | GEO
2021-07-01 | E-MTAB-10681 | biostudies-arrayexpress
2013-10-18 | GSE50923 | GEO
2007-01-08 | GSE5744 | GEO
2012-12-06 | GSE42739 | GEO